Allena Pharmaceuticals Inc (ALNA)

Ticker: ALNA Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BRENNER LOUIS MD President and CEO Executive Director
Transaction date
Sale
Price
419.78
Quantity 42,038 -39.6%
Value US$4,127,575
BRENNER LOUIS MD President and COO Officer
Transaction date
Sale
Price
457.59
Quantity 67,561 -29.6%
Value US$2,628,014
WHOLIHAN EDWARD Chief Financial Officer Officer
Transaction date
Sale
Price
260.34
Quantity 70,734 -18.9%
Value US$2,454,992
BRENNER LOUIS MD President and CEO Officer
Transaction date
Sale
Price
1.36
Quantity 103,116 -41.6%
Value US$140,238
HBM BioCapital II LP Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 71,428 +4.6%
Value US$999,992
Third Rock Ventures II, L.P. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 215,000 +8.3%
Value US$3,010,000
Topper James N Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 500,000 +17.7%
Value US$7,000,000
Bessemer Venture Partners VII L.P. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 36,000 +1.6%
Value US$504,000
Kraus Stephen
Transaction date
Purchase
Price
0.00
Quantity 0
Value US$0
TEPPER ROBERT I Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 215,000 +8.3%
Value US$3,010,000
FHM VI, L.L.C. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 500,000 +17.7%
Value US$7,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2021-11-17 2021-11-15 S Sale

President and CEO

Executive Director
42,038 -39.6%
419.78
US$4,127,575
42,038 -39.6% 419.78 US$4,127,575
2021-05-12 2021-05-10 S Sale

President and COO

Officer
67,561 -29.6%
457.59
US$2,628,014
67,561 -29.6% 457.59 US$2,628,014
2020-12-18 2020-12-17 S Sale

Chief Financial Officer

Officer
70,734 -18.9%
260.34
US$2,454,992
70,734 -18.9% 260.34 US$2,454,992
2020-12-18 2020-12-17 S Sale

President and CEO

Officer
103,116 -41.6%
1.36
US$140,238
103,116 -41.6% 1.36 US$140,238
2017-11-08 2017-11-06 B Purchase HBM BioCapital II LP Large shareholder
71,428 +4.6%
14.00
US$999,992
71,428 +4.6% 14.00 US$999,992
2017-11-06 2017-11-06 B Purchase Third Rock Ventures II, L.P. Large shareholder
215,000 +8.3%
14.00
US$3,010,000
215,000 +8.3% 14.00 US$3,010,000
2017-11-06 2017-11-06 B Purchase Topper James N Large shareholder
500,000 +17.7%
14.00
US$7,000,000
500,000 +17.7% 14.00 US$7,000,000
2017-11-06 2017-11-06 B Purchase Bessemer Venture Partners VII L.P. Large shareholder
36,000 +1.6%
14.00
US$504,000
36,000 +1.6% 14.00 US$504,000
2017-11-06 2017-11-06 B Purchase Kraus Stephen
0
0.00
US$0
0 0.00 US$0
2017-11-06 2017-11-06 B Purchase TEPPER ROBERT I Large shareholder
215,000 +8.3%
14.00
US$3,010,000
215,000 +8.3% 14.00 US$3,010,000
2017-11-06 2017-11-06 B Purchase FHM VI, L.L.C. Large shareholder
500,000 +17.7%
14.00
US$7,000,000
500,000 +17.7% 14.00 US$7,000,000